Aries Wealth Management Seres Therapeutics, Inc. Transaction History
Aries Wealth Management
- $357 Million
- Q4 2024
A detailed history of Aries Wealth Management transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Aries Wealth Management holds 15,000 shares of MCRB stock, worth $10,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$10,800
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MCRB
# of Institutions
75Shares Held
41.3MCall Options Held
2.96MPut Options Held
228K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$16.6 Million5.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$4.23 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.01MShares$1.45 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.81MShares$1.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.27 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $89.3M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...